Ngaahi fakalelei'i 'o e Peptide
Pepitaiti Siakale
What is Cyclic Peptide?
Peptide cyclization to form cyclic peptides or cyclized peptides is a frequently used strategy for the development of peptides with enhanced conformational stability compared to their linear analogs. Cyclic peptides have proven to be useful for several applications, including the mimicry of protein secondary structures, such as protein loops, and the optimization of peptide ligands with increased binding potency, filifilimānako, and enhanced protease stability.
Cyclization configurations
The primary ligation approaches to synthesize lactam cyclic peptides are head-to-tail, tafaʻaki-seini-ki-he-tafaʻaki-seini, head-to-side-chain, and side-chain-to-tail,depending on the location of the functional groups within the peptide sequence.

Head to Tail
·Occurs between N-terminus to C-terminus.
·Via Amide bond formation (lactamization).
·Most frequently used cyclization conferring greater stability.

Side Chain to Head
Occurs between N-terminus and an internal COOH
(e.g. the ß-COOH-group of Asp or γ-COOH-group of Glu).

Side Chain to tail
Occurs between internal NH2s and C-terminus
(e.g. the ε-NH2–group of Lys).

Side Chain to Side Chain
Occurs between Side chain of Lysine (ε-NH2–group of Lys) to Aspartic or Glutamic acid (γ-COOH-group).
Ngaahi Lave Faka'ali'ali
Design and NMR Studies of Cyclic Peptides Targeting the N-Terminal Domain of the Protein Tyrosine Phosphatase YopH
We report on the design and evaluation of novel cyclic peptides targeting the N-terminal domain of the protein tyrosine phosphatase YopH from Yersinia. Cyclic peptides have been designed based on a short sequence from the protein SKAP-HOM [DE(pY)DDPF (pY = phosphotyrosine)], and they all contain the motif DEZXDPfK (where Z is a phosphotyrosine or a non-hydrolyzable phosphotyrosine mimetic, X is an aspartic acid or a leucine and f is a d-phenylalanine). These peptides present a ‘head to tail’ architecture, enabling cyclization through formation of an amide bond in between the side chains of the first aspartic acid and the lysine residues. Chemical shift perturbation studies have been carried out to monitor the binding of these peptides to the N-terminal domain of YopH. Peptides containing a phosphotyrosine moiety exhibit binding affinities in the low micromolar range; substitution of the phosphotyrosine with one of its non-hydrolyzable derivatives dramatically reduces the binding affinities. These preliminary studies may pave the way for the discovery of more potent and selective peptidebased ligands of the YopH N-terminal domain which could be further investigated for their ability to inhibit Yersiniae infections.
Ngaahi Ngaue Fakalelei'i 'o e Peptide Fekau'aki
pepitaiti kalaikosaila
pepitaiti kalaikosaila
Ko e glycosylation 'o e peptide ko ha fakalelei'i 'o e covalent 'e lava ke malava ke fakalelei'i 'a e ngaahi 'ulungaanga fakatu'asino 'o e peptides .
Lau ha me'a lahi angepeptide Fosifolila
peptide Fosifolila
'E lava ke hoko 'a e fosfola 'i he Serine . (S, Ke hoko), Teleonini (T, Thr) mo e Tailosini . (Y, Tyr) ngaahi seini tafa'aki 'e he fa'u 'o e fehokotaki'anga phosphoester
Lau ha me'a lahi angePeptides kuo fakapipiki
Peptides kuo fakapipiki
Fakafe'iloaki 'o e ongo 'esiti 'amino ta'efakanatula 'oku 'i ai 'a e α-methyl ., α-alkenyl ngaahi kulupu lolotonga 'a e synthesis 'o e konga fefeka 'o e ngaahi seini peptide ..
Lau ha me'a lahi angePepitaiti Siakale
Pepitaiti Siakale
'Oku fakalahi 'e he siakale 'o e peptide 'a e tu'unga ma'u 'o e conformational 'o e peptides . ('o fakatatau ki he'enau ngaahi analogues fakalaine .) pea ko ha founga angamaheni ia 'i he fakalakalaka 'o e peptide ..
Lau ha me'a lahi angefakalelei'i 'o e peptide
A'usia lahi 'i he fakalelei'i 'o e peptide ., 'oatu 'a e ngaahi founga mo'ui lahi ki he fakatotolo peptide ..